• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T cells in atherosclerosis.动脉粥样硬化中的 T 细胞。
Int Immunol. 2013 Nov;25(11):615-22. doi: 10.1093/intimm/dxt043.
2
Macrophages and immune cells in atherosclerosis: recent advances and novel concepts.动脉粥样硬化中的巨噬细胞与免疫细胞:最新进展与新概念
Basic Res Cardiol. 2015;110(4):34. doi: 10.1007/s00395-015-0491-8. Epub 2015 May 7.
3
Current advances in understanding of immunopathology of atherosclerosis.当前对动脉粥样硬化免疫病理学认识的进展。
Virchows Arch. 2011 Feb;458(2):117-23. doi: 10.1007/s00428-010-1006-5. Epub 2010 Nov 11.
4
The Two Faces of Interleukin-17A in Atherosclerosis.白细胞介素-17A在动脉粥样硬化中的两面性
Curr Drug Targets. 2017;18(7):863-873. doi: 10.2174/1389450117666161229142155.
5
Antigen-induced immunomodulation in the pathogenesis of atherosclerosis.抗原诱导的免疫调节在动脉粥样硬化发病机制中的作用
Clin Dev Immunol. 2008;2008:723539. doi: 10.1155/2008/723539.
6
The complex role of T-cell-based immunity in atherosclerosis.基于T细胞的免疫在动脉粥样硬化中的复杂作用。
Curr Atheroscler Rep. 2008 Jun;10(3):236-43. doi: 10.1007/s11883-008-0037-8.
7
Functional crosstalk between T cells and monocytes in cancer and atherosclerosis.肿瘤和动脉粥样硬化中 T 细胞与单核细胞的功能串扰。
J Leukoc Biol. 2020 Jul;108(1):297-308. doi: 10.1002/JLB.1MIR0420-076R. Epub 2020 Jun 12.
8
Immunometabolism in atherosclerosis: a new understanding of an old disease.动脉粥样硬化中的免疫代谢:对一种古老疾病的新认识。
Trends Biochem Sci. 2024 Sep;49(9):791-803. doi: 10.1016/j.tibs.2024.06.003. Epub 2024 Jun 27.
9
T cell subsets and functions in atherosclerosis.T 细胞亚群及其在动脉粥样硬化中的功能。
Nat Rev Cardiol. 2020 Jul;17(7):387-401. doi: 10.1038/s41569-020-0352-5. Epub 2020 Mar 16.
10
Atherosclerosis antigens as targets for immunotherapy.动脉粥样硬化抗原作为免疫治疗的靶点。
Nat Cardiovasc Res. 2023 Dec;2(12):1129-1147. doi: 10.1038/s44161-023-00376-x. Epub 2023 Dec 11.

引用本文的文献

1
Cellular aspects of immunity involved in the development of atherosclerosis.动脉粥样硬化发展过程中涉及的免疫细胞方面。
Front Immunol. 2025 Jan 29;16:1461535. doi: 10.3389/fimmu.2025.1461535. eCollection 2025.
2
Thrombo-CARE-cardioembolic stroke etiology in cryptogenic stroke suggested by fibrin-/platelet-rich clot histology : Thrombo-CARE (configuration analysis to refine etiology).富含纤维蛋白/血小板的凝块组织学提示隐源性卒中中心源性栓塞性卒中病因:血栓-CARE(用于明确病因的构型分析)
Wien Med Wochenschr. 2025 Jun;175(9-10):227-236. doi: 10.1007/s10354-024-01060-w. Epub 2024 Nov 11.
3
Targeting Unc5b in macrophages drives atherosclerosis regression and pro-resolving immune cell function.靶向巨噬细胞中的 Unc5b 可促进动脉粥样硬化消退和促解决免疫细胞功能。
Proc Natl Acad Sci U S A. 2024 Oct 29;121(44):e2412690121. doi: 10.1073/pnas.2412690121. Epub 2024 Oct 22.
4
Inflammatory and Immune Mechanisms for Atherosclerotic Cardiovascular Disease in HIV.HIV 相关动脉粥样硬化性心血管疾病的炎症与免疫机制
Int J Mol Sci. 2024 Jul 1;25(13):7266. doi: 10.3390/ijms25137266.
5
Lymphocyte-to-Red Blood Cell Ratio-The Guide Star of Acute Coronary Syndrome Prognosis.淋巴细胞与红细胞比值——急性冠脉综合征预后的指南之星。
Healthcare (Basel). 2024 Jun 16;12(12):1205. doi: 10.3390/healthcare12121205.
6
Blood Cell Ratios Unveiled: Predictive Markers of Myocardial Infarction Prognosis.血细胞比例揭秘:心肌梗死预后的预测标志物
Healthcare (Basel). 2024 Apr 13;12(8):824. doi: 10.3390/healthcare12080824.
7
Interactions Between HDL and CD4+ T Cells: A Novel Understanding of HDL Anti-Inflammatory Properties.高密度脂蛋白(HDL)与CD4 + T细胞之间的相互作用:对HDL抗炎特性的新认识。
Arterioscler Thromb Vasc Biol. 2024 Jun;44(6):1191-1201. doi: 10.1161/ATVBAHA.124.320851. Epub 2024 Apr 25.
8
RNA Sequencing of Whole Blood in Premature Coronary Artery Disease: Identification of Novel Biomarkers and Involvement of T Cell Imbalance.全血 RNA 测序在早发冠状动脉疾病中的应用:新型生物标志物的鉴定及 T 细胞失衡的参与。
J Cardiovasc Transl Res. 2024 Jun;17(3):638-647. doi: 10.1007/s12265-023-10465-8. Epub 2023 Dec 1.
9
Targeting foam cell formation to improve recovery from ischemic stroke.靶向泡沫细胞形成以改善缺血性中风的恢复。
Neurobiol Dis. 2023 Jun 1;181:106130. doi: 10.1016/j.nbd.2023.106130. Epub 2023 Apr 15.
10
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence.秋水仙碱在动脉粥样血栓形成中的作用:分子机制和临床证据。
Int J Mol Sci. 2023 Jan 27;24(3):2483. doi: 10.3390/ijms24032483.

本文引用的文献

1
Genomic responses in mouse models poorly mimic human inflammatory diseases.小鼠模型中的基因组反应与人类炎症性疾病的反应相差很大。
Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3507-12. doi: 10.1073/pnas.1222878110. Epub 2013 Feb 11.
2
Measurement of MHC/peptide interactions by gel filtration or monoclonal antibody capture.通过凝胶过滤或单克隆抗体捕获来测量MHC/肽相互作用。
Curr Protoc Immunol. 2013 Feb;Chapter 18:Unit 18.3.. doi: 10.1002/0471142735.im1803s100.
3
T-helper 2 immunity is associated with reduced risk of myocardial infarction and stroke.辅助性 T 细胞 2 型免疫与心肌梗死和中风风险降低相关。
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):637-44. doi: 10.1161/ATVBAHA.112.300871. Epub 2013 Jan 10.
4
Treg-mediated suppression of atherosclerosis requires MYD88 signaling in DCs.调节性 T 细胞介导的动脉粥样硬化抑制需要树突状细胞中的 MYD88 信号传导。
J Clin Invest. 2013 Jan;123(1):179-88. doi: 10.1172/JCI64617. Epub 2012 Dec 21.
5
Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis.动态 T 细胞-APC 相互作用维持动脉粥样硬化中的慢性炎症。
J Clin Invest. 2012 Sep;122(9):3114-26. doi: 10.1172/JCI61758. Epub 2012 Aug 13.
6
Transforming growth factor-β: transforming plaque to stability.转化生长因子-β:将斑块转化为稳定状态。
Eur Heart J. 2013 Dec;34(48):3684-6. doi: 10.1093/eurheartj/ehs228. Epub 2012 Jul 26.
7
Low levels of circulating CD4+FoxP3+ T cells are associated with an increased risk for development of myocardial infarction but not for stroke.循环中 CD4+FoxP3+T 细胞水平低与心肌梗死的发展风险增加相关,但与中风无关。
Arterioscler Thromb Vasc Biol. 2012 Aug;32(8):2000-4. doi: 10.1161/ATVBAHA.112.251579. Epub 2012 May 24.
8
CD8+ T cells mediate the athero-protective effect of immunization with an ApoB-100 peptide.CD8+ T 细胞介导了用载脂蛋白 B-100 肽免疫的动脉保护作用。
PLoS One. 2012;7(2):e30780. doi: 10.1371/journal.pone.0030780. Epub 2012 Feb 9.
9
Statins induce the accumulation of regulatory T cells in atherosclerotic plaque.他汀类药物可诱导粥样斑块中调节性 T 细胞的积累。
Mol Med. 2012 May 9;18(1):598-605. doi: 10.2119/molmed.2011.00471.
10
The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment.IL-17A/IL-17RA 轴通过调节主动脉髓样细胞募集发挥促动脉粥样硬化作用。
Circ Res. 2012 Mar 2;110(5):675-87. doi: 10.1161/CIRCRESAHA.111.261784. Epub 2012 Feb 2.

动脉粥样硬化中的 T 细胞。

T cells in atherosclerosis.

机构信息

Department of Internal Medicine, Division of Rheumatology, Allergy and Immunology, University of California at San Diego Medical Center, La Jolla, CA 92093, USA.

出版信息

Int Immunol. 2013 Nov;25(11):615-22. doi: 10.1093/intimm/dxt043.

DOI:10.1093/intimm/dxt043
PMID:24154816
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3806170/
Abstract

Atherosclerosis is a chronic inflammatory disease of the artery wall. Atherosclerotic lesions contain monocytes, macrophages, smooth muscle cells and T lymphocytes. Here, we review the role of T-lymphocyte subsets in atherosclerosis. Among CD4⁺T cells, T(h)1 cells are pro-atherogenic, T(reg) cells are athero-protective and the role of T(h)2 and T(h)17 cells remains unclear. The role of follicular helper T cells in atherosclerosis remains unknown, as is the role of CD8⁺T cells. NKT cells bind glycolipid antigens and exert a pro-atherogenic role. The antigen specificity of T-cell responses in atherosclerosis is poorly understood. In order to enable antigen-specific prevention or therapy, a better understanding of these mechanisms is needed.

摘要

动脉粥样硬化是动脉壁的一种慢性炎症性疾病。动脉粥样硬化病变中含有单核细胞、巨噬细胞、平滑肌细胞和 T 淋巴细胞。在这里,我们回顾了 T 淋巴细胞亚群在动脉粥样硬化中的作用。在 CD4⁺T 细胞中,T(h)1 细胞是促动脉粥样硬化的,T(reg)细胞是抗动脉粥样硬化的,而 T(h)2 和 T(h)17 细胞的作用尚不清楚。滤泡辅助 T 细胞在动脉粥样硬化中的作用尚不清楚,CD8⁺T 细胞也是如此。NKT 细胞结合糖脂抗原并发挥促动脉粥样硬化作用。动脉粥样硬化中 T 细胞反应的抗原特异性了解甚少。为了能够进行抗原特异性预防或治疗,需要更好地了解这些机制。